Authors: Kantharidis, P El-Osta, S de Silva, M Lee, G Hu, XF Zalcberg, J

Citation: P. Kantharidis et al., Regulation of MDR1 gene expression: emerging concepts, DRUG RESIST, 3(2), 2000, pp. 99-108

Authors: Zalcberg, J Hu, XF Slater, A Parisot, J El-Osta, S Kantharidis, P Chou, ST Parkin, JD

Citation: J. Zalcberg et al., MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines, PROSTATE C, 3(2), 2000, pp. 66-75

Authors: El-Osta, A Kantharidis, P Zalcberg, J

Citation: A. El-osta et al., Absolute quantitation of MDR1 transcripts using heterologous DNA standards- Validation of the competitive RT-PCR (CRT-PCR) approach, BIOTECHNIQU, 26(6), 1999, pp. 1114

Authors: de Silva, MG Kantharidis, P Scherer, SW Rayeroux, K Campbell, L Tsui, LC Zalcberg, JR

Citation: Mg. De Silva et al., Physical mapping of a tandem duplication on the long arm of chromosome 7 associated with a multidrug resistant phenotype, CANC GENET, 110(1), 1999, pp. 28-33

Authors: Hu, XF Slater, A Rischin, D Kantharidis, P Parkin, JD Zalcberg, J

Citation: Xf. Hu et al., Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line, BR J CANC, 79(5-6), 1999, pp. 831-837

Authors: Hu, XF Slater, A Kantharidis, P Rischin, D Juneja, S Rossi, R Lee, G Parkin, JD Zalcberg, JR

Citation: Xf. Hu et al., Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia, BLOOD, 93(12), 1999, pp. 4086-4095